China Biologic to report Q2 results

Biologics |  Company results | By BioSpectrum Bureau  | 2 Comment | 31 Jul, 2013

Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, will rel...Read more

Oncotest, Debiopharm identify biomarker candidates

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first bio...Read more

EMA recommends MSD's melanoma drug

Biologics |  Regulatory | By BioSpectrum Bureau  | 5 Comment | 27 May, 2015

Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...Read more

Intrexon appoints new VP and CIO

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2013

Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business deve...Read more

China Biologic clocks sales of $53.6 mn

Biologics |  Company results | By BioSpectrum Bureau  | 60 Comment | 07 Aug, 2013

Singapore: China Biologic Products reported its unaudited financial results for the second quarter of 2013. Total sales ...Read more

China Biologic reports 21.1% growth in sales revenue

Biologics |  Company results | By BioSpectrum Bureau  | 116 Comment | 10 Aug, 2012

Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announce...Read more

GE launches new software for molecular screening

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for...Read more

Biochips firm AyoxxA gets $3.37 million funding

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

Singapore: AyoxxA Biosystems, an international biotechnology company, has closed a $3.37 million (2.6 million Euro) seri...Read more

China's JHL Biotech raises $35 million

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2014

Singapore: China based emerging biopharmaceutical company, JHL Biotech, has closed a Series B financing round of $35 mil...Read more

bioCSL inks a deal with Immucor

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and N...Read more

Promega opens new facility in Shanghai

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biologi...Read more

Novel protein complex to combat gastric cancer

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI) at National University of Singapore (NU...Read more

China Biologic names David Gao as CEO

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Singapore: China Biologic Products, one of the leading plasma-based biopharmaceutical companies in China, has appointed ...Read more

Shimadzu launches smart device enabled HPLC system

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HP...Read more

Clearbridge BioMedics raises $7.2 million funding

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

Singapore: Singapore's Clearbridge BioMedics has closed a $7.2 million (S$9 million) Series B financing, led by Vertex V...Read more

Agilent launches Multispan Liquid Handling System

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

Singapore: Agilent Technologies has launched Encore Multispan Liquid Handling System, featuring an array of unique techn...Read more

Patrys offers human antibodies for cancer cure

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

Traditionally, researchers have utilized rodents to generate antibodies that attack human cancer tissues. In most cases,...Read more

MedImmune, WuXi form joint venture

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing c...Read more